As of Feb 21
| +0.0025 / +18.52%|
The 1 analysts offering 12-month price forecasts for Endonovo Therapeutics Inc have a median target of 1.15, with a high estimate of 1.15 and a low estimate of 1.15. The median estimate represents a +7,087.50% increase from the last price of 0.02.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.